Guizhou Yibai Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Yibai Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Jinling Pharmaceutical Company Limited
sales of 3.58 billion Chinese Renmimbi [US$529.82 million]
of which 73%
was Medicine Manufacture),
JiangSu Bicon Pharmaceutical Listed Co
(3.72 billion Chinese Renmimbi [US$551.49 million]
of which 65%
was Pharmaceutical Intermediates), and
Renhe Pharmacy Company Limited
(3.57 billion Chinese Renmimbi [US$528.26 million]
of which 99%
During the year ended December of 2016, sales at
Guizhou Yibai Pharmaceutical Co., Ltd. were 3.69 billion Chinese Renmimbi (US$546.02 million).
increase of 11.6%
versus 2015, when the company's sales were 3.30 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Guizhou Yibai Pharmaceutical Co., Ltd.
(and since 2011, sales have increased a total of 94%).